Inmedix Presentations: Past and Future
September 12, 2018. Cleveland Clinic. "An introduction to the potential diagnostic, therapeutic and health economic impact of immuno-autonomics."
September 16, 2018. Washington Rheumatology Alliance meeting, Leavenworth, WA. "Immuno-autonomics: a lifeline to the unsustainable cost of autoimmune disease care."
October 16, 2018. Outsourcing in Clinical Trials, Pacific Northwest 2017 meeting, Vancouver, BC, Canada. Cutting-edge medicine within the Pacific Northwest to ensure successful clinical studies. Round Table: Conducting start-up clinical trials in the Pacific Northwest with limited resources.
October 22, 2018. The American College of Rheumatology annual meeting, Chicago: "Autonomic Neuroregulation of Autoimmune Disease" Study Group, co-chaired by Andrew J. Holman MD and Professor and GSK SrVP Paul-Peter Tak, MD PhD.
Selected Past Presentations
May 1-3, 2018. The British Society for Rheumatology. "Quantified impact of autonomic nervous system state on immunotherapy treatment outcome in rheumatoid arthritis" [abstract], Liverpool, UK.
March 27, 2018. GTC Biomarker Summit, San Diego. "Immuno-autonomics: actionable biomarkers of the (immediate) future."
March 26, 2018. Inmedix COO Steven Daly presents Inmedix at the Life Science Innovation NorthWest (LSINW) conference, Seattle, WA.
March 20, 2018. Rainier Club presentation "Immuno-autonomics", Seattle, WA.
March 14, 2018. Inmedix to present at the Venture West Summit, Santa Clara, CA.
February 5, 2018. Inmedix presents at the Biotech & Money World Congress, London.
January 31-February 1, 2018. Inmedix presents at the Health Tech Austin: the Medical Device Summit, Austin, Texas.
January 9, 2018. Inmedix presents at the Biotech Showcase and at the Precision Medicine & Medtech Showcase at JP Morgan, San Francisco.
December 6, 2017. Inmedix named a Top Innovator at the New England Venture Summit, Boston.
November 14, 2017. Inmedix company presentation at Biotech & Money Inve$tival Showcase, London.
November 6, 2017. American College of Rheumatology annual meeting, San Diego. November 4-9, 2017. Abstract #1049: Heart rate variability testing with autonomic nervous system optimization: could it change the course of spending for rheumatoid arthritis patients in the U.S.? An exploratory economic modeling minimal model analysis.
October 26, 2017. Outsourcing in Clinical Trials, Pacific Northwest 2017 meeting, Seattle. “Creative funding: no support, no sponsor, no phase 1 safety data, no problem” and “What effective ANS 'stress' stratification of subjects means for future clinical trials.”
January, 2017. "Autonomic neuroregulation of rheumatoid arthritis: a paradigm shift in therapeutic strategy”, Rheumatology Grand Rounds, Brigham & Women’s Hospital, Boston.
November, 2016. "Autonomic neuroregulation of autoimmune disease" Study Group Co-chair with Paul-Peter Tak MD PhD. American College of Rheumatology annual meeting, Washington, DC.
November, 2015. "Autonomic neuroregulation of rheumatoid arthritis" Study Group Co-chair with Paul-Peter Tak, MD PhD. American College of Rheumatology annual meeting, San Francisco.
November 2014. “Fibromyalgia and positional cervical cord compression (PC3)”, 2014 Primary Care Update, Phoenix.
April, 2012. “Practical management approaches to fibromyalgia”, Colorado Academy of Family Physicians, Colorado Springs,
April, 2012; “Practical management approaches to fibromyalgia”, Oklahoma Academy of Family Physicians, Tulsa, OK,
June, 2012; “Practical management approaches to fibromyalgia”, Iowa Academy of Family Physicians annual meeting, Des Moines, IA.
October, 2012. “FM: what it is and what it is not”, Women’s Healthcare Conference, Seattle.
May, 2011. “Managing fibromyalgia in women”, AAPI Chapters of greater New York & New Jersey, Bridgewater, NJ.
October, 2010. “Unraveling the mystery of fibromyalgia: the critical role of positional cervical cord compression (PC3)”, Kingston Hospital Education Centre, London.
October, 2009. “Cervical spinal cord compression and fibromyalgia”, Grand Rounds, Evergreen Hospital, Kirkland, WA.
June, 2009. “Autonomic regulation of RA: prediction of disease expression and anti-TNF treatment response”, Rheumatology Grand Rounds, Hospital for Special Surgery, New York.
April, 2009. “Fibromyalgia, dysautonomia, hypermobility and positional myelopathy”, Pain and Hypermobility Syndromes, British Society for Rheumatology annual meeting, Glasgow.
December, 2008. “FM: what it is, what it isn’t and what to do about it.” Guy’s Hospital, London.
September, 2006. “Fibromyalgia and Positional Cervical Myelopathy: a novel an unrecognized co-morbidity”, National Fibromyalgia Research Association meeting on the Neurology of Fibromyalgia. Salem, OR.
June, 2006. “Fibromyalgia Clinical Update”, Grand Rounds, Evergreen Hospital, Kirkland, WA
March, 2006. "Fibromyalgia and Dopamine”, National Fibromyalgia Association, Garden Grove, CA.
May, 2004. “Central Autonomic Nervous System Regulation, Dopamine Agonists and Fibromyalgia”, Organization for Fatigue and Fibromyalgia Education and Research (OFFER), Salt Lake City, UT.
May, 2003. “Update on Fibromyalgia: Dopamine Agonists”, Arthritis Foundation of Wisconsin, Madison, WI.
October, 2002. “Neurology and New Treatment Modalities in Fibromyalgia”, National Fibromyalgia Research Association, Portland, OR